Dennis Slamon is Director at BIOMARIN PHARMACEUTICAL INC (BMRN). They have made 1 open-market trade across 1 company since 2022, most recently 2024-03-18.
CIK 0001603265
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BMRN | 40,809 | $2.2M |
Shares reported on the most recent Form 4, priced at the 2024-03-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BMRN | SELL | 2022-02-28 | 2022-03-02 | $78.33 | $957K | -2.2% | +2.0% | -3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.